32(10): 51. In Japanese. Hotta, M., Sato, Y., Iwata, S., Yamashjta, N., Sunakawa, K., Oikawa, T., Tanaka, R., Watanabe, K., Takayama, H. Yajuma, M., Sekiguchi, S., Arai, S., Sakurai, T., and Mutai, M. 1987. Clinical effects .of Bifidobacterium preparations on pediatric intractable diarrhea. Keio J. Med. 1987: 298-314.
Hughes, J.B., and Hoover, D.G. 1991 . Bifidobacteria: Their potential for use in American dairy products. Food Technol. 45(4): 74, 76, 78-80, 83. Hylemon, P.B. and Glass, T.L. 1983. Bio-transformation of bile acids and cholesterol by the intestinal microfiora. Chpt. 9 in Hentges (1983), pp. 189-213. Kanbe, M.  1988. Lactic acid bacteria as physiologically functional food. New Food Ind. 30(1): 77-87. In Japanese. Kanbe, M. 1992a. Uses of intestinal lactic acid  bacteria  and  health.  Chpt.   13 in Nakazawa and Hosono (1992), p. 300. Kanbe, M. 1992b. Cancer control and fermented milk. Chpt. 17 in Nakazawa and Hosono, p. 377.
Kato, Y., Shirayanagi, S., Mizutani, J., and Hayakawa, K. 1992. The effects of soybean oligosaccharides on intestinal metabolic activity. Personal communication, Soya Oligo Japan Co. R&D Center, Tokyo. In Japanese.
Kohwi,   Y., Imai, K., Tamura, Z., and Hashimoto, Y. 1978. Antitumor effect of Bifidobacterium infantis in mice. Gann (Cancer) 69: 613-618.
Kohwi, Y., Hashimoto, J., and Tamura, Z. 1982. Antitumor and immunological adjuvant effect of Bifidoba.cteriu.rn infantis in mice. Bifidobacteria Microflora 1(1): 61-68. Koizumi, T., Mituya, N., Mukuta, T., Fujita, S., Ishiau, H-., and Yoshioka, H. 1980. Effects of administration of Bifidobacterium preparation (BBG-02) on hepatic coma. Sogo Rinsho (Total Clinics) 29: 2473-2478. In Japanese.
Komai, M. 1990. Intestinal microfiora and health. New Food Ind. 32(12): 39-50. In Japanese.
Komai, M. and Nanno, M. 1992. Intestinal microfiora and longevity. Chpt. 15 in Nakazawa and Hosono, p. 325. Kurmann, J.A. and Rasic, J.Lj. 1991. The health potential of products containing bi-fidobacteria. Chpt. 6 in "Therapeutic Properties of Fermented Milk," ed. R.K. Robinson, p. 117. Elsevier Applied Science Publishing Co., Inc., New York. Mann. G.V. and Spoerry, A. 1974. Studies of a surfactant and cholesteremia in the Masai. Am. J. Clin. Nutr. 27: 464. Masai, T., Wada, K., Hayakawa, K., Yoshihara, I., and Mitsuoka, T. 1987. Effects of soybean oligosaccharides on human intestinal flora and metabolic activities. Japan. J. Bacteriol. 42(1): 313. Mata, L.J., Carillo, C., and Villatoro, E. 1969. Fecal microfiora in healthy persons in a preindustnal region. Appl. Microbiol. 17: 596-602.
Matsunami, T., Mochizuki, N., and Masai, T. 1992. The effects of a soybean oligosaccha-rides-containing soft drink on defecation and gastrointestinal conditions. Personal communication, Soya Oligo Japan Co., R&D Center. In Japanese.

Mitsuoka, T. 1982. Recent trends in research on intestinal flora. Bifidobacteria Microflora 1(1): 3-24.
Mitsuoka, T. 1990a. "Tales of Intestinal Microflora." Iwanami Shoten Publisher, Tokyo. In Japanese.
Mitsuoka, T. 1990b. Health and intestinal microflora. New Food Ind. 32(10): 1. In Japanese.
Mitsuoka, T. 1990c. Bifidobacteria and their role in human health. J. Ind. Microbiol. 6: 263-267.
Mizutaru, T. 1992. The relationship between microorganisms and the physiology of aging. Chpt. 14 in Nakazawa and Hosono, p. 305.
Murphy, E.L., Horsiey, H., and Burr, H.K. 1972. Fractionation of dry bean extracts whjch increase carbon dioxide egestion in human flatus. J. Agric. Food Chem. 20: 813.
Mutai, M. 1978. Characteristics of "Mil-Mil," a Bifidobacterium fermented milk. New Food Ind. 20(8): 17. In Japanese. Muting, D., Escherich, D., and Mayer, J. P. 1968. The effect of Bifidobacterium bifi-dam on intestinal bacterial flora and toxic protein metabolites in chronic liver diseases. Am. J. Proctol. 19: 336-342. Nakaya, R. 1984. Role of Bifidobacterium in enteric infection. Bifidobacteria Microflora 3: 3-9.
Nakazawa, Y. and Hosono, A. 1992. "Functions of Fermented Milk." Elsevier Applied Science, New York.
Nowak, J. and Steinkraus, K.H. 1988. Effect of tempeh fermentation of peas on their potential flatulence productivity as measured by gas production and growth of Clostridium perfringens. Nutr. Repts. Intl. 38: 1163-1171.
Okamura, N., Nakaya, R., Yokota, H., Yanai, N., and Kawashima, T. 1986. Interaction of Shigelta with Bifidobacteria. Bifidobacteria Microflora 5: 51-55. Orla-Jensen, S., Olsen, E., and Geill, T. 1945. Senility and intestinal flora. Kgl. Danske Vidensk. Selskab. Biol. Skifter 3: 3-38. Quaker Oats Co. 1993. Internal report D-
93077. Unpublished. Barrington, 111. Rasic, J. and Kurmann, J. 1983. Nutritive and health values of dairy foods containing bifidobacteria. Chpt. 6 in "Bifidobacteria and Their Role," pp. 81-101. Birkhauser Verlag Basel, Basel, Switzerland. Reddy, N.R., Pierson, M.D., Sathe, S.K., and Salunkhe, D.K. 1984. Chemical, nutritional and physiological aspects of dry bean carbohydrates—A review. Food Chem. 13: 48.
Renner, H.W. and Munzner, R. 1991. The possible role of prebiotics as dietary antimutagens. Mutagen Res. 262: 239-245. Roberts, A.K., van Biervliet, J.P., and Harzer, G. 1985. Factors of human milk influencing the bacterial flora of infant faeces. In "Composition and Physiological Properties of Human Milk," ed. J. Schaub, pp. 259-269. Elsevier, Amsterdam. Saito, Y., Takano, T., and Rowland, I. 1992. Effects of soybean oligosaccharides on the human gut microflora in in vitro culture. Microbial Ecol. Health Dis. 5: 105-111. Spiegel, J.E., Tose, R., Karabell, P., Frankos, V.H., and Schmitt, D.F. 1994. Safety and benefits of fructooligosaccharides as food

ingredients. Food Technol. 48(1): 85-89. Suzuki, K. 1985. Intestinal microflora and carcinogenesis. Biseibutsu (Microbes) 1(4): 12. In Japanese.
Suzuki, Y., Kaizu, H., and Yamaguchi, Y. 1991. Effect of cultured milk on serum cholesterol concentrations in rats fed high-choiesterol diets. Animal Sci. Technol. (Japan) 62(6): 565-571. In Japanese. Takasoye, M., Inoue, N., and Knuma, C. 1990. Clinical investigation of feces improvements by soybean oligosaccharides. Rinsho toh Kenkyu 'Clinics and Research) 67: 304—310. In Japanese. Taketomo, T., Oda, M., Oyama, K., Kanbe, M., and Tsuchiya, F. 1983. A high molecular weight polysaccharide MPS-82 and its application. Japan Kokai Tokkyo Koho (Japanese Patent Publication), Sho 58-203913. In Japanese.
Tamura, Z. 1983. Nu-.riology of bifidobacteria. Bifidobacteria Microflora 2(1): 3-16. Tannenbaum, S.R. 1979. Endogenous formation of nitrite and N-nitroso compounds. Proc. EX Intl. Symp. Princess Takamatsu Cancer Res. Fund. Tokyo, pp. 211-220. Tokunaga, T., Oku, T., and Hosoya, N. 1986. Influence of chronic intake of new sweetener fructooligosaccharide (Neosugar) on growth and gastrointestinal function of the rat. J. Nutr. Sci. Vitaminol. 32: 111-121. Wada, K, Watabe, J., Mizutani, J., Suzuki, H., Kiriu, N., Hayakawa, K., and Yamaguchi, C. 1991. Effects of soybean oligosaccharides intake on fecal microflora, enzyme activity, ammonia and frequency of evacuation in elderly persons. Bifidus 4: 135-140. In Japanese. Wagner, J.R., Carson, J.F., Becker, R., Gumbmann, M.R., and Danhof, I.E. 1977. Comparative flatulence activity of beans and bean fractions for man and rat. J. Nutr. 107: 680.
Wilkins, T.D. and Van Tassel, R.L. 1983a. Production of intestinal mutagens. Chpt. 12 in Hentges (1983), p. 265. Wilkins, T.D. and Van Tassel, R.L. 1983b. Production of intestinal mutagens. Chpt. 12 in Hentges (1983), p. 272. Yasuda, H., Hisamatsu, M., Adachi, G., Niwa, T., and Sekizawa, T. 1981. Anti-tumor immune-activator EES-163S obtained by culturing bacteria of genus Bifidobacterium. Japan Kokai Tokkyo Koho (Japanese Patent Publication), Sho 56-58491. In Japanese. Yasuda, H., Adachi, G., Takizawa, T., and Uchida, S. 1983. Antitumor substance and the method of preparation. Japan Kokai Tokkyo Koho (Japanese Patent Publication), Sho 56-103194. In Japanese.
The author acknowledges the assistance of Geraidine Horton, Head Librarian, Quaker Oats Co.
For a copy of tables briefly summarizing the literature on effect of oligosaccharide intake on (a) changes in levels of bifidobacteria and other bacteria, (b) reduction of toxic metabolites and detrimental enzymes in the intestine, (c) constipation, and (d) serum cholesterol reduction, contact the author.
—Edited by Neil H. Mermelstein, Senior Associate Editor

OCTOBER 1994—FOOD TECHNOLOGY   65